VANCOUVER, British Columbia & MUMBAI, India--(BUSINESS WIRE)--SaNOtize Research and Development Corp. and Indian company, Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--SaNOtize Research & Development Corp., (“SaNOtize”), a Canadian anti-infective-focused therapeutics company, today announced an oversubscribed $24 million ...

(MENAFN- GetNews) Enovid's SaNOtize Nitric Oxide Nasal Spray (NONS) is formulated for effective antiviral protection to arm the immune system against a wide range of respiratory viruses, including ...

There are currently zero authorized or approved preventative COVID therapies in the U.S. but Canadian biotech SaNOtize wants to change that, charting plans to move a nasal spray into a phase 3 study ...

OurCrowd portfolio company SaNOtize Research & Development Corp. has received interim approval to sell its COVID-19 treatment Nitric Oxide Nasal Spray (NONS). The spray is said to protect users from ...

Israel and New Zealand have given interim approval for the sale of biotech firm SaNOtize Research and Development's Nitric Oxide Nasal Spray (NONS) which could help prevent transmission of the ...

Glenmark Pharmaceuticals Limited (Glenmark), a global, innovation-driven pharmaceutical company and Canadian pharmaceutical company SaNOtize Research & Development Corp. announced launch of its nitric ...

U.K. physicians have begun clinical development of a nasal spray designed to prevent infection with the coronavirus and treat mild to moderate cases of COVID-19. The spray delivers nitric oxide into ...

SaNOtize has raised $24 million in Series B funding in a rojnd led by global investment crowdfunding platform OurCrowd and Horizons Ventures. The Agricultural Bank of China International also ...

Add Yahoo as a preferred source to see more of our stories on Google. JERUSALEM/WELLINGTON (Reuters) - Israel and New Zealand have given interim approval for the sale of biotech firm SaNOtize Research ...